Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
WALTHAM, Mass., Aug. 23, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in four upcoming investor conferences. The four conferences are:
- The Wells Fargo Global Healthcare Conference at the Westin Boston Waterfront in Boston on Wednesday, September 6. Tim Pearson, Executive Vice President and CFO of TESARO, is scheduled to present an overview of the Company’s business and development programs at 9:40 AM ET on September 6, and will also host meetings with investors.
- The 12th Annual Citi Biotech Day at the Mandarin Oriental Hotel in Boston on Wednesday, September 6 and Thursday, September 7, 2017. Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, are scheduled to participate in an analyst-led fireside chat from 10:00 to 10:50 AM ET on Thursday, September 7, and will also host meetings with investors.
- The Baird 2017 Global Healthcare Conference at the InterContinental New York Barclay in New York City on Wednesday, September 6. Grant Bogle, Senior Vice President and Chief Commercial Officer of TESARO, is scheduled to participate in an analyst-led fireside chat from 9:40 to 10:10 AM ET on September 6, and will also host meetings with investors.
- The Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology at the Lotte New York Palace in New York City on Thursday, September 28, 2017. Lonnie Moulder and Mary Lynne Hedley, Ph.D. will participate in an analyst-led fireside chat from 1:00 to 1:55 PM ET, and in meetings with investors.
Live webcasts of the presentations at the Wells Fargo, Citi, Baird and Leerink Partners conferences will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company’s website for 14 days following the conferences.
About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
For additional information, please contact: Jennifer Davis 1.781.325.1116 [email protected]
